United States · FDA National Drug Code directory
PALIPERIDONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72658-1255_3e4a14d9-8d90-5f05-e063-6294a90a110e
- Product NDC
- 72658-1255
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- PALIPERIDONE
- Labeler
- Eskayef Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251002
- Source listing expiry
- 20261231
Source-listed ingredients
- PALIPERIDONE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1255-1) · 72658-1255-1
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1255-2) · 72658-1255-2
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72658-1255-3) · 72658-1255-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →